← Eichor
Study identifier: NCT06575322 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Effects of Neoadjuvant Therapy With Carboplatin, Paclitaxel Combined With Anti-PD-1 Drugs on Pain, Anxiety and Depression in Patients With Resectable Head and Neck Squamous Cell Carcinoma

Condition: Head and Neck Squamous Cell Carcinoma  ·  Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

PhaseN/A
Planned participants302
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

The goal of this observational study is to learn about the Effects of neoadjuvant therapy with carboplatin, paclitaxel combined with anti-PD-1 drugs on pain, anxiety and depression in patients with operable head and neck squamous cell carcinoma: a prospective cohort study

This description comes directly from the study's public registry record.

Talk to the study team

Song Fan, Doctor  ·  13570536658  ·  fansong2@mail.sysu.edu.cn

Pei-Chia Lu  ·  18359253576  ·  lupeic@mail2.sysu.edu.cn

Always discuss trial participation with your own doctor first.

Locations (1)

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityGuanzhou, Guangdong, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06575322